BAC
Bank of America Corporation
BAC has the edge over MBWM overall, supported by stronger valuation and stronger modeled upside.
MBWM
Mercantile Bank Corporation
MBWM trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MBWM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MBWM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MBWM.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over MBWM in the historical PE scenario, which offers more potential upside but is not a forecast.
MBWM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.3x | $41.04 | -33% |
| Fair | 9.2x | $51.59 | -16% |
| Expensive | 11x | $59.31 | -2.9% |
| Current | 11x | $61.11 | — |
| Forward | 11x | $61.11 | — |
Historical ranges are pointers, not guarantees.
MBWM's PE is in its expensive range at 10.9x. On analysts' estimates for next year's earnings, today's price would be 10.7x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over MBWM on the outlook, with more favorable valuation and profitability expectations.
MBWM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MBWM, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over MBWM on earnings, with more consistent year-over-year improvement.
MBWM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.72 | +1.7% |
| Q3 2026 | $5.62 | +6.8% |
| Q2 2026 | $5.69 | +13% |
| Q1 2026 | $5.58 | +16% |
| Q4 2025 | $5.47 | +11% |
| Q3 2025 | $5.26 | +5.6% |
| Q2 2025 | $5.02 | -0.8% |
| Q1 2025 | $4.80 | -7% |
| Q4 2024 | $4.93 | -3.9% |
MBWM earned $5.62 per share over the past year, up 6.8% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MBWM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
MBWM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $73.2M | +17% |
| Q2 2026 | $68.8M | +13% |
| Q1 2026 | $67.6M | +18% |
| Q4 2025 | $62.1M | +6% |
| Q3 2025 | $62.4M | +7.6% |
| Q2 2025 | $60.9M | +7.4% |
| Q1 2025 | $57.3M | -1.7% |
| Q4 2024 | $58.5M | +2.8% |
MBWM's revenue has grown year over year for six quarters in a row: $73M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -4.4 points |
| Q2 2026 | 45% | +2.8 points |
| Q1 2026 | 40% | -1.6 points |
| Q4 2025 | 42% | +2.3 points |
| Q3 2025 | 44% | +1.6 points |
| Q2 2025 | 43% | +1.2 points |
| Q1 2025 | 42% | -4.3 points |
| Q4 2024 | 40% | -4.6 points |
MBWM has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
MBWM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.1M | +104% |
| Q2 2026 | $15.3M | +$23.1M |
| Q1 2026 | $28.3M | +$31.3M |
| Q4 2025 | $5.6M | -91% |
| Q3 2025 | $23.1M | +$31.2M |
| Q2 2025 | -$7.8M | -186% |
| Q1 2025 | -$3M | -107% |
| Q4 2024 | $59.9M | +$67.2M |
MBWM has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over MBWM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
MBWM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +8K shares |
| 1 year | +6.4% | +1M shares |
| 3 years | +7.9% | +1.3M shares |
| 5 years | +9% | +1.4M shares |
| Available history | +5.3% | +877K shares |
MBWM has 17M diluted shares, up 6.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $1.6M |
| Q3 2021 | $8.9M |
| Q2 2021 | $7.3M |
| Q1 2021 | $3.5M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MBWM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
MBWM has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MBWM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.0 | Neutral |
| Stochastic | 55.7 | Neutral |
MBWM's weekly RSI is 60 (neutral) and its Stochastic is 56 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
MBWM PE vs Financial Services Sector
| Metric | MBWM | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 87 | 63 | 24 pts above |
MBWM has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MBWM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.8 | 2.2% above |
| 20 week MA | $59.8 | 2.2% above |
| 50 week MA | $54.8 | 12% above |
| 100 week MA | $50.1 | 22% above |
| 200 week MA | $43.5 | 41% above |
MBWM has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
MBWM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.7 | $27.2 | -26% |
| 2021 | $27.2 | $35.1 | +29% |
| 2022 | $35.1 | $33.8 | -3.7% |
| 2023 | $33.8 | $40.4 | +20% |
| 2024 | $40.4 | $44.8 | +11% |
| 2025 | $44.8 | $48.7 | +8.8% |
| 2026 YTD | $48.7 | $61.1 | +25% |
MBWM has the edge over BAC on returns for 2026, with the stronger performance.